We are live on ! Find out more
AWM

Aevitas Wealth Management Portfolio holdings

AUM $169M
1-Year Est. Return 9.55%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
-9.55%
3 Year Est. Return
+36.41%
5 Year Est. Return
+72.53%
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$7.71M
Cap. Flow
+$1.15M
Cap. Flow %
1.05%
Top 10 Hldgs %
29.89%
Holding
461
New
33
Increased
162
Reduced
63
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$511K
2
VTV icon
Vanguard Value ETF
VTV
+$489K
3
PEP icon
PepsiCo
PEP
+$236K
4
VB icon
Vanguard Small-Cap ETF
VB
+$129K
5
NVDA icon
NVIDIA
NVDA
+$78K

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$262K
2
VYGR icon
Voyager Therapeutics
VYGR
+$211K
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$188K
4
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$161K
5
BSCM
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
+$92.7K

Sector Composition

Rank Sector Weight
1 Healthcare 12.78%
2 Technology 12.74%
3 Consumer Staples 11.44%
4 Consumer Discretionary 8.84%
5 Financials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEV icon
351
Ambev
ABEV
$48.4B
$9K 0.01%
2,000
– –
BLK icon
352
Blackrock
BLK
$170B
$9K 0.01%
19
– –
HXL icon
353
Hexcel
HXL
$8.3B
$9K 0.01%
128
– –
IVE icon
354
iShares S&P 500 Value ETF
IVE
$49.6B
$9K 0.01%
77
+1
+1% +$115
MET icon
355
MetLife
MET
$62.7B
$9K 0.01%
202
-848
-81% -$38.7K
MS icon
356
Morgan Stanley
MS
$333B
$9K 0.01%
+200
New +$9.77K
SLAB icon
357
Silicon Laboratories
SLAB
$7.17B
$9K 0.01%
100
– –
STX icon
358
Seagate
STX
$169B
$9K 0.01%
191
– –
WMGI
359
DELISTED
Wright Medical Group Inc
WMGI
$9K 0.01%
309
– –
AET
360
DELISTED
Aetna Inc
AET
$9K 0.01%
42
-42
-50% -$8.21K
CELG
361
DELISTED
Celgene Corp
CELG
$9K 0.01%
100
– –
CSX icon
362
CSX Corp
CSX
$94.2B
$8K 0.01%
327
+300
+1,111% +$7.15K
SCSC icon
363
Scansource
SCSC
$1.16B
$8K 0.01%
200
– –
SEE
364
DELISTED
Sealed Air
SEE
$8K 0.01%
+200
New +$8.27K
TEI
365
Templeton Emerging Markets Income Fund
TEI
$314M
$8K 0.01%
800
– –
WPP icon
366
WPP
WPP
$4.59B
$8K 0.01%
107
+3
+3% +$234
A icon
367
Agilent Technologies
A
$39.7B
$7K 0.01%
105
– –
AEF
368
abrdn Emerging Markets Equity Income Fund
AEF
$342M
$7K 0.01%
1,057
– –
AZN icon
369
AstraZeneca
AZN
$267B
$7K 0.01%
92
+1
+1% +$76
BG icon
370
Bunge Global
BG
$22.8B
$7K 0.01%
+100
New +$6.6K
IWP icon
371
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
$7K 0.01%
98
– –
PCG icon
372
PG&E
PCG
$39.2B
$7K 0.01%
150
– –
SAM icon
373
Boston Beer
SAM
$1.93B
$7K 0.01%
25
– –
WU icon
374
Western Union
WU
$2.58B
$7K 0.01%
350
+1
+0.3% +$19
GAP
375
The Gap Inc
GAP
$7.28B
$7K 0.01%
245
+2
+0.8% +$60
13 14
15
16 17

Similar funds

CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
BA
Bennicas & Associates Portola Valley, California $173M AUM 1.55% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return
RCA
Rex Capital Advisors Providence, Rhode Island $152M AUM 17.51% 1-Year Est. Return
SCM
Snowhook Capital Management New York $187M AUM 31.24% 1-Year Est. Return
WWA
WC Walker & Associates Fullerton, California $189M AUM 16.91% 1-Year Est. Return

Aevitas Wealth Management's Q3 2018 Portfolio in Review

As of Q3 2018, Aevitas Wealth Management held 461 positions worth $110M, up 7.5% from $103M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Aevitas Wealth Management's Q3 2018 filing shows 33 new, 162 increased, 63 reduced and 7 closed positions. Its largest new stake was Weyerhaeuser: 1,110 shares worth $36K. The largest sale was CRISPR Therapeutics, an estimated $262K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Staples.

  • Aevitas Wealth Management's largest Q3 2018 buy was Weyerhaeuser: 1,110 shares worth $36K.
  • Aevitas Wealth Management added most to Microsoft in Q3 2018, an estimated $511K increase.
  • Aevitas Wealth Management's biggest Q3 2018 reduction was CRISPR Therapeutics, cutting an estimated $262K.
  • Aevitas Wealth Management fully exited Wgl Holdings in Q3 2018, selling an estimated $71K.
  • Aevitas Wealth Management's ten largest holdings make up 30% of its $110M portfolio in Q3 2018.
  • Aevitas Wealth Management opened 33 new positions and closed 7 in Q3 2018.
  • Aevitas Wealth Management's portfolio value rose 7.5% quarter-over-quarter to $110M.

Based on Aevitas Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.